Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ, PuroR)
Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
B Cell Overview | Thermo Fisher Scientific - US
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
T Cell Markers and B Cell Markers
B cells (mouse) | Miltenyi Biotec | USA
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
CD19 - The Marker, the Antibodies | Bio-Rad
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect
How To Identify B Cell Subsets Using Flow Cytometry
A Guide to Breg Markers | Biocompare: The Buyer's Guide for Life Scientists
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO